Major National Heart, Lung, and Blood Institute COPD Research Grant Funding FY 2022
Overview
Organization: National Heart, Lung, and Blood Institute
Start Date: 10/2021
End Date: Ongoing
Primary Goal: Goal 4: Increase and sustain research to better understand the prevention, pathogenesis, diagnosis, treatment, and management of COPD.
Secondary Goal(s):
Objective(s):
- Help expand, coordinate, and optimize COPD research efforts
- Improve methods for earliest detection and diagnosis and develop effective strategies for preventing the onset and progression of COPD
- Define and characterize the pathogenesis of COPD heterogeneity
- Develop personalized medicine for COPD based on the pathogenesis and clinical heterogeneity
- Promote research that can lead to strategies that help prevent the onset and progression of COPD and improve the quality of COPD care and management
Collaboration: We worked alone
Activity Type: Research
Activity Description
The National Heart, Lung, and Blood Institute (NHLBI) awards funding to research organizations to implement activities that further the goals and objectives of the COPD National Action Plan. For fiscal year 2022, NHLBI awarded large research grants to seven organizations to support their efforts in raising awareness to better understand the prevention, pathogenesis, diagnosis, treatment, and management of COPD. Organizations funded this cycle include: Brigham and Women's Hospital; Columbia University Health Sciences; Dartmouth College; Florida International University; Nota Labortories, LLC; SUNY Downstate Medical Center; and University of California, San Francisco.Funded research topics included:
• COPD Susceptibility, Heterogeneity, and Progression: Proteomics and Genetics;
• DeepCOPD: Development and Implementation of Deep Learning to Predict and Prevent COPD Health Care Encounters;
• Photochemical Generation of Gas Phase Nitric Oxide from Immobilized S-Nitrosothiols for Biomedical Applications;
• Precision phenotyping of emphysema in the elderly: the MESA Lung Study;
• Rehabilitation in Safety-Net Environments (RISE) for COPD;
• Resetting the Clock in HIV associated COPD;
• The Role of HuR in HIV related COPD
Audience
General Audience: Researchers
Focused Audience: n/a
Program Reach: National
Type of Area: N/A
Setting: Workplace
Cost and Funding Sources
It was funded through NHLBI and funds to be allotted to grantees.Impact Analysis
The FY2022 cycle awarded grants to seven organizations. Results of their programs are in progress.Advice or Lessons Learned
N/ARelated Links
- COPD Susceptibility, Heterogeneity, and Progression: Proteomics and Genetics
- DeepCOPD: Development and Implementation of Deep Learning to Predict and Prevent COPD Health Care Encounters
- Photochemical Generation of Gas Phase Nitric Oxide from Immobilized S-Nitrosothiols for Biomedical Applications
- Precision phenotyping of emphysema in the elderly: the MESA Lung Study
- Rehabilitation in Safety-Net Environments (RISE) for COPD
- Resetting the Clock in HIV associated COPD
- The Role of HuR in HIV related COPD
Contact Information
National Heart, Lung, and Blood Institute
Program Analyst
Bethesda
Maryland